title: Functional characterization of a muscarinic receptor stimulating gastrin release from rabbit antral G-cells in primary culture.
abstract: In previous studies carbachol-induced stimulation of gastrin release from antral G-cells in primary culture suggested the presence of muscarinic acetylcholine receptors on this cell type. Therefore, we attempted to pharmacologically characterize the muscarinic acetylcholine receptor subtype involved. Enzymatically isolated rabbit antral mucosal cells (0.8% G-cells) were separated by counterflow elutriation yielding a fraction (1.7% G-cells) that was placed in culture on collagen-coated well plates. After 24-36 h of culture 13.0 +/- 2.4% of total adherent cells were immunoreactive for gastrin as shown by immunocytochemical staining using the avidin-biotin complex method. In this preparation basal gastrin release ranged from 3.3 +/- 0.3 to 4.1 +/- 0.3% of total cellular content. Maximal gastrin release in response to the acetylcholine receptor agonist carbachol (10(-4) M) or the selective muscarinic receptor agonist arecaidine propargyl ester (10(-4) M) was 8.5 +/- 0.4% and 7.6 +/- 0.4% of total cellular content, respectively. The EC50 values were 3.7 +/- 0.5 x 10(-6) M carbachol and 1.8 +/- 0.4 x 10(-6) M arecaidine propargyl ester. At a concentration of 10(-6) M the non-selective muscarinic receptor antagonist atropine and the muscarinic M3 receptor preferring antagonist hexahydro-sila-difenidol (HHSiD; M3 > or = M1 > M2) completely inhibited gastrin release in response to carbachol (Ki values: 52 x 10(-9) M atropine and 29 x 10(-9) M HHSiD) and arecaidine propargyl ester (Ki values: 11 x 10(-9) M atropine and 13 x 10(-9) M HHSiD).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Internal Medicine II, Technical University of Munich, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Weigert
authors.forename: K
authors.initials: K
authors.lastname: Schaffer
authors.forename: U
authors.initials: U
authors.lastname: Wegner
authors.forename: V
authors.initials: V
authors.lastname: Schusdziarra
authors.forename: M
authors.initials: M
authors.lastname: Classen
authors.forename: W
authors.initials: W
authors.lastname: Schepp
mesh_terms: D000818:Animals; D001115:Arecoline / Q000031:analogs & derivatives / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001570:Benzodiazepinones / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects; D002469:Cell Separation; D002478:Cells, Cultured; D005755:Gastrins / Q000378:metabolism*; D007150:Immunohistochemistry; D008297:Male; D018727:Muscarinic Antagonists; D010276:Parasympatholytics / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology; D010890:Pirenzepine / Q000494:pharmacology; D011706:Pyloric Antrum / Q000166:cytology / Q000187:drug effects*; D011817:Rabbits; D011976:Receptors, Muscarinic / Q000187:drug effects*
chemical_list: D001570:Benzodiazepinones; D005755:Gastrins; D018727:Muscarinic Antagonists; D010276:Parasympatholytics; D010880:Piperidines; D011976:Receptors, Muscarinic; C015688:arecaidine; C069054:AQ-RA 741; D010890:Pirenzepine; D001115:Arecoline; D001285:Atropine; D002217:Carbachol; C046773:hexahydrosiladifenidol